Selected article for: "mRNA cap and translation initiation"

Author: Jia, Yan; Polunovsky, Vitaly; Bitterman, Peter B.; Wagner, Carston R.
Title: Cap‐Dependent Translation Initiation Factor eIF4E: An Emerging Anticancer Drug Target
  • Cord-id: 1902wpg7
  • Document date: 2012_4_11
  • ID: 1902wpg7
    Snippet: Cancer cells tend to be more highly dependent on cap‐dependent translation than normal tissues. Thus, proteins involved in the initiation of cap‐dependent translation have emerged as potential anti‐cancer drug targets. Cap‐dependent translation is initiated by the binding of the factor eIF4E to the cap domain of mRNA. Detailed x‐ray crystal and NMR structures are available for eIF4E in association with cap‐analogs, as well as domains of other initiation factors. This review will summ
    Document: Cancer cells tend to be more highly dependent on cap‐dependent translation than normal tissues. Thus, proteins involved in the initiation of cap‐dependent translation have emerged as potential anti‐cancer drug targets. Cap‐dependent translation is initiated by the binding of the factor eIF4E to the cap domain of mRNA. Detailed x‐ray crystal and NMR structures are available for eIF4E in association with cap‐analogs, as well as domains of other initiation factors. This review will summarize efforts to design potential antagonist of eIF4E that could be used as new pharmacological tools and anti‐cancer agents and. Insights drawn from these studies should aid in the design of future inhibitors of eIF4E dependent translation initiation. © 2012 Wiley Periodicals, Inc. Med Res Rev., 32, No. 4, 786‐814, 2012

    Search related documents:
    Co phrase search for related documents
    • activate translation and acute respiratory syndrome coronavirus: 1
    • active area and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • active component and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5
    • active component and liver weight: 1
    • activity dependent and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • activity effect and acute respiratory syndrome coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome coronavirus and additional interaction: 1, 2
    • acute respiratory syndrome coronavirus and liver transaminase: 1, 2, 3, 4
    • acute respiratory syndrome coronavirus and liver weight: 1, 2
    • acute respiratory syndrome coronavirus and living cell: 1